Author

A. Vaughan-Jackson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

M. Schilling· 2 shared W. James· 2 shared C. Browne· 1 shared E. Pires· 1 shared H. Borrmann· 1 shared I. Pedroza-Pacheco· 1 shared J. A. McKeating· 1 shared J. Gilbert-Jaramillo· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. Schilling

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Hypoxia dampens innate immune signalling at early time points and increases Zika virus replication in iPSC-derived macrophages

M. Schilling, A. Vaughan-Jackson, W. James, J. McKeating

This study shows that hypoxia reduces interferon-stimulated gene expression and increases Zika virus replication in iPSC-derived macrophages.

bioRxiv · Feb 21, 2023 · PreprintMicrobiology

Differentiation of Human induced Pluripotent Stem Cells to Authentic Macrophages using Fully Defined, Serum Free, Open Source Media

A. Vaughan-Jackson, S. Stodolak, K. H. Ebrahimi, C. Browne, P. K. Reardon, E. Pires, J. Gilbert-Jaramillo, S. A. Cowley, W. S. James

This paper describes two fully defined, serum-free, open-source media for culturing human iPSCs and differentiating them into macrophages, showing improved characteristics compared to commercial media.

bioRxiv · Oct 27, 2020Immunology

Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication

H. Borrmann, R. Davies, M. Dickinson, I. Pedroza-Pacheco, M. Schilling, A. Vaughan-Jackson, W. James, P. Balfe, P. Borrow, J. A. McKeating, X. Zhuang

This study shows that REV-ERB agonists inhibit HIV-1 replication by suppressing its promoter activity in multiple cell types.

Scientific Reports · Aug 6, 2020Peer-reviewedMicrobiology